Blood Preparation Market: Evolving into a Major Market Opportunity
Global
Blood Preparation Market: Overview
Blood
components refer to products derived from platelet-rich plasma or whole blood.
Blood components such as platelets, plasma, red blood cells, and white blood
cells are derived from blood by the process of phlebotomy or hemapheresis
through the technique of differential centrifugation. These blood components
are separated from whole blood in hospital laboratories and blood centers, and
are administered to patients suffering from various diseases through
transfusion. The whole blood is often collected and separated into major components
before transfusion. However, automated collections are becoming increasingly
popular nowadays and only blood components that are needed for transfusion are
collected.
To
access full report, please visit : http://www.transparencymarketresearch.com/blood-preparation-market.html
On the basis of product
type, the global blood preparation market has been segmented into whole blood
and blood components. While whole blood comprises platelets, plasma, red cells,
and granulocytes, blood components constitute whole blood components, leukocyte
reduced RBC, packed red cells, frozen plasma, and platelet concentrate.
According to the antithrombotic and anticoagulant type, the blood preparation
market has been divided into anticoagulants, fibrinolytics, and platelet
aggregation inhibitors. Major application segments in the blood preparation
market include renal impairment, thrombocytosis, and pulmonary embolism.
Global Blood Preparation Market: Drivers and Restraints
The growing demand for
blood transfusion across emergency departments in hospitals has boosted the
growth of the global blood preparation market. The rise in blood disorders such
as thrombocytosis and the increasing requirement for blood during accidents and
surgical procedures have supported the growth of the market.
According to the Centers
for Disease Control and Prevention, conditions such as deep vein thrombosis
(DVT) and pulmonary embolism (PE) lead to over 60,000 deaths in the U.S. every
year. Various initiatives taken by the National Institutes of Health and other
regulatory bodies to spread awareness about the complications associated with
these conditions have also propelled the market’s growth.
However, during blood
transfusion, the chances of transmission of diseases such as viral hemorrhagic
fever, HIV, and Hepatitis B are high. This is the single major restraining
factor impacting the growth of the global blood preparation market. The overall
market has a significant opportunity to grow with the development of high speed
technology to separate blood components without losing their activity. The
introduction of new oral anticoagulants and the re-launch of drugs such as
Urokinase, the growing demand for source plasma, and the need for specific
blood components such as packed red blood cells will create new growth
opportunities for the market.
Global Blood Preparation Market: Region-wise Outlook
The global blood
preparation market has been segmented into four key regions: Europe, Asia
Pacific, North America, and Rest of the World. North America has been
contributing significantly to the growth of the market owing to the presence of
a robust healthcare infrastructure. In the U.S., the collection, preparation,
storage, and transport of blood is regulated by the FDA. Other federal agencies
are working toward the implementation of health insurance portability standards
to achieve adequate reimbursement for blood components.
However, during the
forecast period, the Asia Pacific blood preparation market is anticipated to
expand rapidly due to various initiatives taken by governments, especially in
countries such as India and China. The positive growth of the healthcare sector
across Japan and Australia will also support the growth of the regional market.
Global Blood Preparation Market: Competitive Landscape
Some of the key players in
the global blood preparation market are GlaxoSmithKline PLC, Pfizer Inc., Leo
Pharma Inc., Celgene Corp, Sanofi Aventis, Baxter Healthcare Corp., Shandong East
Chemical Industry Co., Bristol-Myers Squibb Co., and AstraZeneca Co. The blood
preparation market worldwide is being driven by technology. As a result, market
players are investing heavily in research and development to introduce novel
and cost-effective drugs.
Request
A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12467
The report
offers a comprehensive evaluation of the market. It does so via in-depth
qualitative insights, historical data, and verifiable projections about market
size. The projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report serves
as a repository of analysis and information for every facet of the market,
including but not limited to: Regional markets, technology, types, and
applications.
About
Us
Transparency
Market Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive blend of
quantitative forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources and various tools and
techniques to gather and analyze information.
TMR’s data
repository is continuously updated and revised by a team of research experts so
that it always reflects the latest trends and information. With extensive
research and analysis capabilities, Transparency Market Research employs
rigorous primary and secondary research techniques to develop distinctive data sets
and research material for business reports.
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Comments